SB 774 - This act requires 25% of the funds received from subsequent participating manufacturers in the Tobacco Master Settlement Agreement that are deposited into the Life Sciences Research Trust Fund, be expended by the Life Sciences Research Board.

The board shall expend 25% of such money to fund the program that awards grants for the establishment of umbilical cord blood banks and for the expansion of existing umbilical cord blood banks. It shall expend 75% of such money to fund life science projects involving the study, use, or therapies involving human stem cells derived from non-embryonic and non-fetal sources.


Return to Main Bill Page